{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T02:02:01Z","timestamp":1775613721579,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["U01CE0025000"],"award-info":[{"award-number":["U01CE0025000"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jsat.2021.108615","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T12:13:03Z","timestamp":1630411983000},"page":"108615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Characteristics and health care events of patients admitted to treatment for both heroin and methamphetamine compared to patients admitted for heroin only"],"prefix":"10.1016","volume":"132","author":[{"given":"Sanae","family":"El Ibrahimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Hallvik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirbee","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian","family":"Leichtling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Todd","family":"Korthuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel M.","family":"Hartung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jsat.2021.108615_bb0005","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1080\/10826084.2016.1271432","article-title":"Heroin and methamphetamine injection: An emerging drug use pattern","volume":"52","author":"Al-Tayyib","year":"2017","journal-title":"Substance Use & Misuse"},{"issue":"1","key":"10.1016\/j.jsat.2021.108615_bb0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/ADM.0000000000000669","article-title":"\" Like yin and Yang\": perceptions of methamphetamine benefits and consequences among people who use opioids in rural communities","volume":"15","author":"Baker","year":"2021","journal-title":"Journal of Addiction Medicine"},{"issue":"3","key":"10.1016\/j.jsat.2021.108615_bb0015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1360-0443.2002.00058.x","article-title":"Factors associated with non-fatal heroin overdose: Assessing the effect of frequency and route of heroin administration","volume":"97","author":"Brugal","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2021.108615_bb0020","author":"CDC Statistics, C. N. C. f. H"},{"key":"10.1016\/j.jsat.2021.108615_bb0025","author":"Centers for Disease Control Prevention"},{"issue":"12","key":"10.1016\/j.jsat.2021.108615_bb0030","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1111\/add.14755","article-title":"Pharmacotherapy for methamphetamine\/amphetamine use disorder\u2014A systematic review and meta-analysis","volume":"114","author":"Chan","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2021.108615_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108193","article-title":"A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders","volume":"216","author":"Chan","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2021.108615_bb0040","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1186\/s12913-017-2538-z","article-title":"Trends in substance use admissions among older adults","volume":"17","author":"Chhatre","year":"2017","journal-title":"BMC Health Services Research"},{"issue":"5","key":"10.1016\/j.jsat.2021.108615_bb0045","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/aje\/kwf222","article-title":"Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City","volume":"157","author":"Des Jarlais","year":"2003","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.jsat.2021.108615_bb0050","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.drugalcdep.2017.10.011","article-title":"Increasing methamphetamine injection among non-MSM who inject drugs in King County, Washington","volume":"182","author":"Glick","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.jsat.2021.108615_bb0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/ajad.13115","article-title":"Increasing heroin-methamphetamine (Goofball) use and related morbidity among Seattle area people who inject drugs","volume":"30","author":"Glick","year":"2021","journal-title":"The American Journal on Addictions"},{"issue":"9","key":"10.1016\/j.jsat.2021.108615_bb0060","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/pds.4254","article-title":"Using prescription monitoring program data to characterize out-of-pocket payments for opioid prescriptions in a state medicaid program","volume":"26","author":"Hartung","year":"2017","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"2","key":"10.1016\/j.jsat.2021.108615_bb0065","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/ADM.0000000000000708","article-title":"Patterns of prescription opioid use prior to self-reported heroin initiation","volume":"15","author":"Hartung","year":"2020","journal-title":"Journal of Addiction Medicine"},{"issue":"12","key":"10.1016\/j.jsat.2021.108615_bb0070","first-page":"1","article-title":"Regional differences in the drugs most frequently involved in drug overdose deaths: United States, 2017","volume":"68","author":"Hedegaard","year":"2019","journal-title":"National Vital Statistics Reports"},{"issue":"4","key":"10.1016\/j.jsat.2021.108615_bb0075","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2105\/AJPH.2019.305527","article-title":"Resurgent methamphetamine use at treatment admission in the United States, 2008\u20132017","volume":"110","author":"Jones","year":"2020","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2021.108615_bb0080","article-title":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)","volume":"363","author":"Langan","year":"2018","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.jsat.2021.108615_bb0085","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/09595230801919494","article-title":"A systematic review of cognitive and behavioural therapies for methamphetamine dependence","volume":"27","author":"Lee","year":"2008","journal-title":"Drug and Alcohol Review"},{"issue":"1","key":"10.1016\/j.jsat.2021.108615_bb0090","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/add.15116","article-title":"Polysubstance use and association with opioid use disorder treatment in the US veterans health administration","volume":"116","author":"Lin","year":"2020","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.jsat.2021.108615_bb0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4065\/81.1.77","article-title":"Methamphetamine abuse: A perfect storm of complications","volume":"81","author":"Lineberry","year":"2006","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.jsat.2021.108615_bb0100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.addbeh.2018.05.013","article-title":"Polydrug use patterns, risk behavior and unmet healthcare need in a community-based sample of women who use cocaine, heroin or methamphetamine","volume":"85","author":"Lorvick","year":"2018","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.jsat.2021.108615_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2020.106478","article-title":"Historical trends of admitted patients by selected substances and their significant patient's level factors [Article]","volume":"109","author":"Mazumder","year":"2020","journal-title":"Addictive Behaviors"},{"issue":"5","key":"10.1016\/j.jsat.2021.108615_bb0110","doi-asserted-by":"crossref","first-page":"774","DOI":"10.15288\/jsad.2016.77.774","article-title":"Prevalence and correlates of heroin\u2013methamphetamine co-injection among persons who inject drugs in San Diego, California, and Tijuana, Baja California, Mexico","volume":"77","author":"Meacham","year":"2016","journal-title":"Journal of Studies on Alcohol and Drugs"},{"issue":"9791","key":"10.1016\/j.jsat.2021.108615_bb0115","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"The Lancet"},{"key":"10.1016\/j.jsat.2021.108615_bb0120","author":"Oregon State"},{"key":"10.1016\/j.jsat.2021.108615_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108089","article-title":"Trends in characteristics of individuals who use methamphetamine in the United States, 2015-2018","volume":"213","author":"Palamar","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2021.108615_bb0130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12954-020-00360-9","article-title":"Motivations for crystal methamphetamine-opioid co-injection\/co-use amongst community-recruited people who inject drugs: A qualitative study","volume":"17","author":"Palmer","year":"2020","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.jsat.2021.108615_bb0135","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","author":"Quan","year":"2005","journal-title":"Medical Care"},{"key":"10.1016\/j.jsat.2021.108615_bb0140","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jsat.2019.10.005","article-title":"Association between methamphetamine use and retention among patients with opioid use disorders treated with buprenorphine","volume":"109","author":"Tsui","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108615_bb0145","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.drugpo.2017.07.009","article-title":"Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users","volume":"49","author":"Wang","year":"2017","journal-title":"International Journal of Drug Policy"},{"issue":"6","key":"10.1016\/j.jsat.2021.108615_bb0150","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.3758","article-title":"Evaluation of amphetamine-related hospitalizations and associated clinical outcomes and costs in the United States","volume":"1","author":"Winkelman","year":"2018","journal-title":"JAMA Network Open"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074054722100341X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074054722100341X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:57:55Z","timestamp":1760039875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074054722100341X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":30,"alternative-id":["S074054722100341X"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108615","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and health care events of patients admitted to treatment for both heroin and methamphetamine compared to patients admitted for heroin only","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108615","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108615"}}